Masimo Corporation (NASDAQ:MASI) Short Interest Up 17.6% in April

Masimo Corporation (NASDAQ:MASI) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totaling 3,818,925 shares, an increase of 17.6% from the March 31st total of 3,248,048 shares. Currently, 7.9% of the company’s stock are short sold. Based on an average daily volume of 697,853 shares, the days-to-cover ratio is presently 5.5 days.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. 180 Wealth Advisors LLC lifted its position in Masimo by 2.5% during the first quarter. 180 Wealth Advisors LLC now owns 2,728 shares of the medical equipment provider’s stock valued at $485,000 after purchasing an additional 66 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Masimo by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after purchasing an additional 66 shares during the period. Clearstead Advisors LLC lifted its position in Masimo by 18.4% during the third quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock valued at $69,000 after purchasing an additional 73 shares during the period. Hantz Financial Services Inc. lifted its position in Masimo by 12.9% during the fourth quarter. Hantz Financial Services Inc. now owns 655 shares of the medical equipment provider’s stock valued at $85,000 after purchasing an additional 75 shares during the period. Finally, Assetmark Inc. lifted its position in Masimo by 5.5% during the fourth quarter. Assetmark Inc. now owns 1,850 shares of the medical equipment provider’s stock valued at $241,000 after purchasing an additional 97 shares during the period. Institutional investors own 85.96% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on MASI. Raymond James Financial downgraded shares of Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday, March 27th. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a research note on Tuesday, February 17th. Piper Sandler downgraded shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price on the stock. in a research note on Tuesday, February 17th. BTIG Research downgraded shares of Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Masimo in a research note on Thursday, January 22nd. Eight equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $181.17.

Masimo Stock Up 0.0%

Shares of NASDAQ MASI traded up $0.05 during midday trading on Friday, hitting $178.48. The stock had a trading volume of 1,040,776 shares, compared to its average volume of 620,464. The business’s 50 day moving average is $177.21 and its 200-day moving average is $153.89. The company has a market cap of $9.59 billion, a P/E ratio of -16.93, a PEG ratio of 1.81 and a beta of 1.13. Masimo has a 52 week low of $125.94 and a 52 week high of $179.00. The company has a quick ratio of 1.47, a current ratio of 2.49 and a debt-to-equity ratio of 0.72.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.